Since activating BRAF mutations are present in a wide variety of human cancer, we hypothesized that BRAF gene mutations are similarly involved in canine cancers, leading to hyperactivation of the MAPK pathway and cell transformation. The gene discussed is BRAF; the disease is cancer.